AngioDynamics, Inc. (ANGO)
$11.52+2.58%Close
SELLCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $476M
- Beta
- 0.30
- P/E (TTM)
- -16.39
- Short % float
- 3.54%
- Days to cover
- 2.2
- SI change
- -3.6%
- 1W
- -23.76%
- 1M
- -24.41%
- vs SPY 1W
- -24.92%
- vs SPY 1M
- -27.40%
Industry peers
FMP comparable companies · ranked by market cap
- BSXSELLBoston Scientific Corporation$62.5BRECOVERYQ 6$42.04+1.64%
- BDXSELLBecton, Dickinson and Company$50.4BBULLQ 21$182.75+0.55%
- PENSELLPenumbra, Inc.$12.5BBULLQ 27$317.52+0.59%
- TFXSELLTeleflex Incorporated$5.5BBEARQ 11$124.19+0.75%
- MMSISELLMerit Medical Systems, Inc.$5.1BBEARQ 13$85.25+2.30%
- LMATBUYLeMaitre Vascular, Inc.$1.8BRECOVERYQ 20$79.64+1.32%
- CNMDSELLCONMED Corporation$1.4BRECOVERYQ 13$45.11-1.53%
- IARTSELLIntegra LifeSciences Holdings Corporation$1.0BCRISISQ 9$13.41+0.22%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ANGO?
- LOPJLB’s latest quantitative signal on AngioDynamics, Inc. (ANGO) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ANGO in?
- AngioDynamics, Inc. (ANGO) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does AngioDynamics, Inc. (ANGO) do?
- AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international…